Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,66 USD | +3,11 % | -1,19 % | +17,73 % |
Métier
Nombre d'employés: 83
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Mental Health Innovations
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +34,76 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States and Germany
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +34,76 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Florian Brand
CEO | Chief Executive Officer | 37 | 01/06/18 |
Srinivas Rao
FOU | Founder | 55 | 01/06/18 |
Anne Johnson
DFI | Director of Finance/CFO | 55 | 01/01/21 |
Kevin Craig
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Arvind Tewari
COO | Chief Operating Officer | 39 | 01/01/21 |
Frank Stegert
CIO | Chief Investment Officer | 41 | - |
Samantha Bender
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Chief Tech/Sci/R&D Officer | 55 | 01/01/20 | |
Chris Lee
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Michael Raven
COO | Chief Operating Officer | - | 01/01/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 57 | 01/01/21 |
Founder | 45 | 01/06/18 | |
Amir Kalali
BRD | Director/Board Member | 58 | 01/01/23 |
Andrea Smiley
BRD | Director/Board Member | 56 | 01/01/21 |
Michael Auerbach
BRD | Director/Board Member | 48 | 01/01/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 167 406 070 | 150 647 814 ( 89,99 %) | 0 | 89,99 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
INTELGENX TECHNOLOGIES CORP. 21,36% | 37 300 000 | 21,36% | 6 229 100 $ |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. |
Pharmaceuticals: Major
|
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+17,73 % | 278 M | |
+54,05 % | 58,71 Md | |
-2,02 % | 41,31 Md | |
+40,01 % | 39,2 Md | |
-10,22 % | 27,4 Md | |
+13,42 % | 26,55 Md | |
-21,60 % | 18,98 Md | |
+2,89 % | 12,51 Md | |
+22,40 % | 11,94 Md | |
+27,49 % | 12,08 Md |
- Bourse
- Actions
- Action ATAI
- Société Atai Life Sciences N.V.